Eldian Biomed (Grant)
Funding Details
Awarder
Inbox
Date Award
August 14, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$10,000
Company Info
Founding Year
2024
Traction
The team is led by Gregor Bordon, supported by the research infrastructure of the University of Bern, including the labs of Prof. Paola Luciani and Prof. Jean Louis Reymond.
Founders
Gregor Bordon
Market
Osteoarthritis therapy
Location
Bern, Switzerland
Company Description

Eldian Biomed is developing CloudLi—a patented microcushion technology of lipid nanoparticles crosslinked with peptide linkers, targeting both inflammation and cartilage wear. The OA therapy market is projected to reach USD 17B by launch, with CloudLi addressing a USD 1–1.4B segment for non-end-stage knee OA in Europe and the US.

Links
Back to HomeBack to Biotechnology DealsView Funding Announcement